These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15827049)

  • 21. Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls.
    Brooks JO; Wang PW; Strong C; Sachs N; Hoblyn JC; Fenn R; Ketter TA
    Bipolar Disord; 2006 Jun; 8(3):248-54. PubMed ID: 16696826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
    Sakai T; Oshima A; Nozaki Y; Ida I; Haga C; Akiyama H; Nakazato Y; Mikuni M
    Neuropathology; 2008 Apr; 28(2):143-50. PubMed ID: 18069969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
    Tian SY; Wang JF; Bezchlibnyk YB; Young LT
    Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives.
    McIntosh AM; Job DE; Moorhead TW; Harrison LK; Lawrie SM; Johnstone EC
    Biol Psychiatry; 2005 Aug; 58(3):254-7. PubMed ID: 15939409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorders of calcium, phosphate and bone: an overview.
    Schalin-Jäntti C
    Minerva Endocrinol; 2018 Jun; 43(2):131-132. PubMed ID: 29160052
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin resistance and postprandial triglyceride levels in primary renal disease.
    Charlesworth JA; Kriketos AD; Jones JE; Erlich JH; Campbell LV; Peake PW
    Metabolism; 2005 Jun; 54(6):821-8. PubMed ID: 15931621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder.
    Kato T
    Cell Calcium; 2008 Jul; 44(1):92-102. PubMed ID: 18177933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired frontal synchronization of spontaneous magnetoencephalographic activity in patients with bipolar disorder.
    Chen SS; Tu PC; Su TP; Hsieh JC; Lin YC; Chen LF
    Neurosci Lett; 2008 Nov; 445(2):174-8. PubMed ID: 18786606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical mechanisms of nephrotoxicity: application for metabolomics.
    Niemann CU; Serkova NJ
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):527-44. PubMed ID: 17696804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional magnetic resonance imaging of executive control in bipolar disorder.
    Roth RM; Koven NS; Randolph JJ; Flashman LA; Pixley HS; Ricketts SM; Wishart HA; Saykin AJ
    Neuroreport; 2006 Jul; 17(11):1085-9. PubMed ID: 16837832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder.
    Frey BN; Walss-Bass C; Stanley JA; Nery FG; Matsuo K; Nicoletti MA; Hatch JP; Bowden CL; Escamilla MA; Soares JC
    Neuroreport; 2007 Oct; 18(15):1567-70. PubMed ID: 17885603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive functioning of bipolar I patients and relatives from families with or without schizophrenia or schizoaffective disorder.
    Antila M; Partonen T; Kieseppä T; Suvisaari J; Eerola M; Lönnqvist J; Tuulio-Henriksson A
    J Affect Disord; 2009 Jul; 116(1-2):70-9. PubMed ID: 19117610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GABA type A receptor alpha5 subunit gene is associated with bipolar I disorder.
    Otani K; Ujike H; Tanaka Y; Morita Y; Katsu T; Nomura A; Uchida N; Hamamura T; Fujiwara Y; Kuroda S
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):108-13. PubMed ID: 15882799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
    Novelli A; Reali EF; Amato M; Dami A; Fallani S; Periti P
    J Chemother; 1989 Jul; 1(4 Suppl):546-8. PubMed ID: 16312526
    [No Abstract]   [Full Text] [Related]  

  • 40. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.